Cargando…

Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors

Polymorphonuclear leukocyte (PMN) chemotaxis has been examined under conditions which allow phase microscope observations of cells responding to controlled gradients of chemotactic factors. With this visual assay, PMNs can be seen to orient rapidly and reversibly to gradients of N-formylmethionyl pe...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1977
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2109936/
https://www.ncbi.nlm.nih.gov/pubmed/264125
_version_ 1782139440811999232
collection PubMed
description Polymorphonuclear leukocyte (PMN) chemotaxis has been examined under conditions which allow phase microscope observations of cells responding to controlled gradients of chemotactic factors. With this visual assay, PMNs can be seen to orient rapidly and reversibly to gradients of N-formylmethionyl peptides. The level of orientation depends upon the mean concentration of peptide present as well as the concentration gradient. The response allows an estimation of the binding constant of the peptide to the cell. In optimal gradients, PMNs can detect a 1% difference in the concentration of peptide. At high cell densities, PMNs incubated with active peptides orient their locomotion away from the center of the cell population. This orientation appears to be due to inactivation of the peptides by the cells. Such inactivation in vivo could help to limit an inflammatory response.
format Text
id pubmed-2109936
institution National Center for Biotechnology Information
language English
publishDate 1977
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21099362008-05-01 Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors J Cell Biol Articles Polymorphonuclear leukocyte (PMN) chemotaxis has been examined under conditions which allow phase microscope observations of cells responding to controlled gradients of chemotactic factors. With this visual assay, PMNs can be seen to orient rapidly and reversibly to gradients of N-formylmethionyl peptides. The level of orientation depends upon the mean concentration of peptide present as well as the concentration gradient. The response allows an estimation of the binding constant of the peptide to the cell. In optimal gradients, PMNs can detect a 1% difference in the concentration of peptide. At high cell densities, PMNs incubated with active peptides orient their locomotion away from the center of the cell population. This orientation appears to be due to inactivation of the peptides by the cells. Such inactivation in vivo could help to limit an inflammatory response. The Rockefeller University Press 1977-11-01 /pmc/articles/PMC2109936/ /pubmed/264125 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors
title Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors
title_full Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors
title_fullStr Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors
title_full_unstemmed Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors
title_short Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors
title_sort ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2109936/
https://www.ncbi.nlm.nih.gov/pubmed/264125